These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 31490419)
1. Only one-third of hepatocellular carcinoma cases are diagnosed via screening or surveillance: a systematic review and meta-analysis. Zhao C; Xing F; Yeo YH; Jin M; Le R; Le M; Jin M; Henry L; Cheung R; Nguyen MH Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):406-419. PubMed ID: 31490419 [TBL] [Abstract][Full Text] [Related]
2. Hepatocellular Carcinoma Screening and Surveillance: Practice Guidelines and Real-Life Practice. Zhao C; Nguyen MH J Clin Gastroenterol; 2016 Feb; 50(2):120-33. PubMed ID: 26583266 [TBL] [Abstract][Full Text] [Related]
3. Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta-analysis of a complex issue. Zhao C; Jin M; Le RH; Le MH; Chen VL; Jin M; Wong GL; Wong VW; Lim YS; Chuang WL; Yu ML; Nguyen MH Liver Int; 2018 Mar; 38(3):503-514. PubMed ID: 28834146 [TBL] [Abstract][Full Text] [Related]
4. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365 [TBL] [Abstract][Full Text] [Related]
5. [Incidence of hepatocellular carcinoma and consequent lessons for its management in Northeastern Hungary]. Papp R; Papp M; Tornai I; Vitális Z Orv Hetil; 2016 Nov; 157(45):1793-1801. PubMed ID: 27817236 [TBL] [Abstract][Full Text] [Related]
6. Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the Netherlands. van Meer S; de Man RA; Coenraad MJ; Sprengers D; van Nieuwkerk KM; Klümpen HJ; Jansen PL; IJzermans JN; van Oijen MG; Siersema PD; van Erpecum KJ J Hepatol; 2015 Nov; 63(5):1156-63. PubMed ID: 26100498 [TBL] [Abstract][Full Text] [Related]
8. Surveillance of the patients at high risk for developing hepatocellular carcinoma in Europe--between guidelines and reality. Săndulescu L; Săftoiu A Ultraschall Med; 2013 Oct; 34(5):483-4. PubMed ID: 24278973 [No Abstract] [Full Text] [Related]
9. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice? Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812 [TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinoma Surveillance: Are We Utilizing It? Selvapatt N; House H; Brown A J Clin Gastroenterol; 2016 Jan; 50(1):e8-e12. PubMed ID: 26018132 [TBL] [Abstract][Full Text] [Related]
12. Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US. Singal AG; Mittal S; Yerokun OA; Ahn C; Marrero JA; Yopp AC; Parikh ND; Scaglione SJ Am J Med; 2017 Sep; 130(9):1099-1106.e1. PubMed ID: 28213044 [TBL] [Abstract][Full Text] [Related]
13. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol. Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722 [TBL] [Abstract][Full Text] [Related]
14. [Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue]. Trinchet JC; Nahon P; Ganne-Carrie N Rev Prat; 2013 Feb; 63(2):222-5. PubMed ID: 23513790 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Tang A; Hallouch O; Chernyak V; Kamaya A; Sirlin CB Abdom Radiol (NY); 2018 Jan; 43(1):13-25. PubMed ID: 28647765 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Montalto G; Cervello M; Giannitrapani L; Dantona F; Terranova A; Castagnetta LA Ann N Y Acad Sci; 2002 Jun; 963():13-20. PubMed ID: 12095924 [TBL] [Abstract][Full Text] [Related]
17. Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis. Farvardin S; Patel J; Khambaty M; Yerokun OA; Mok H; Tiro JA; Yopp AC; Parikh ND; Marrero JA; Singal AG Hepatology; 2017 Mar; 65(3):875-884. PubMed ID: 27531684 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy. Debes JD; Chan AJ; Balderramo D; Kikuchi L; Gonzalez Ballerga E; Prieto JE; Tapias M; Idrovo V; Davalos MB; Cairo F; Barreyro FJ; Paredes S; Hernandez N; Avendaño K; Diaz Ferrer J; Yang JD; Carrera E; Garcia JA; Mattos AZ; Hirsch BS; Gonçalves PT; Carrilho FJ; Roberts LR Liver Int; 2018 Jan; 38(1):136-143. PubMed ID: 28640517 [TBL] [Abstract][Full Text] [Related]
19. Surveillance for hepatocellular carcinoma: how can we do better? Hassett M; Yopp AC; Singal AG Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089 [TBL] [Abstract][Full Text] [Related]
20. Factors affecting screening for hepatocellular carcinoma. Al Hasani F; Knoepfli M; Gemperli A; Kollar A; Banz V; Kettenbach J; Jüni P; Dufour JF Ann Hepatol; 2014; 13(2):204-10. PubMed ID: 24552862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]